Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dekundy, A.
Right arrow Articles by Turski, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dekundy, A.
Right arrow Articles by Turski, W. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 72, 289-295 (2003)
Copyright © 2003 by the Society of Toxicology

NEUROTOXICOLOGY

Dizocilpine Improves Beneficial Effects of Cholinergic Antagonists in Anticholinesterase-Treated Mice

Andrzej Dekundy*,1, Rafal M. Kaminski*,2 and Waldemar A. Turski*,{dagger}

* Department of Toxicology, Institute of Agricultural Medicine, 20-950 Lublin, Poland; and {dagger} Department of Pharmacology and Toxicology, Medical University, 20-090 Lublin, Poland

Mice were administered anticholinesterase pesticides dichlorvos (DDVP) or methomyl (MET). Both DDVP and MET induced dose-dependent seizures and lethality in mice. The muscarinic antagonist atropine (ATR, 1.8 mg/kg) did not prevent seizures but diminished the lethality induced by DDVP or MET. The nicotinic antagonist mecamylamine (MEC, 1 mg/kg) affected neither DDVP-induced seizures nor DDVP- and MET-induced lethality, but diminished MET-induced seizures. At a higher dose (10 mg/kg), MEC attenuated seizures produced by MET, but not DDVP, and decreased lethality of both anticholinesterases. The N-methyl-D-aspartate (NMDA) antagonist dizocilpine (MK-801, 1 mg/kg) prevented DDVP-, but not MET-induced seizures. MK-801 did not affect DDVP- or MET-induced lethality. Concurrent administration of ATR and MK-801 prevented the occurrence of DDVP- but not MET-induced seizures. MK-801 coadministered with ATR enhanced its protective effect against DDVP- or MET-induced lethality in mice. Coinjection of MEC (at both doses studied) and MK-801 completely prevented seizures produced by both acetylcholinesterase (AChE) inhibitors. Coadministration of MEC (1 mg/kg) and MK-801 protected mice against DDVP or MET lethality. MK-801 administered along with MEC at 10 mg/kg enhanced antilethal effects of the nicotinic antagonist in DDVP- or MET-treated mice. With respect to the mechanism underlying anticholinesterase-induced neurotoxicity, muscarinic and nicotinic, as well as NMDA receptors, seem to play major roles. The results suggest that combined treatment with cholinergic and NMDA antagonists might be beneficial in anticholinesterase-induced poisonings.

Key Words: anticholinesterase; NMDA antagonist; atropine; mecamylamine; mice; seizures; lethality; nicotinic; muscarinic.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Exp ToxicolHome page
M. Mercurio-Zappala, J. B. Hack, A. Salvador, and R. S. Hoffman
Pralidoxime in carbaryl poisoning: an animal model
Human and Experimental Toxicology, February 1, 2007; 26(2): 125 - 129.
[Abstract] [PDF]

Home page
 Hum Exp ToxicolHome page
J A Pickrell and F W Oehme
Examining the risks and benefits of considering both the traditional dose-response and hormesis in arriving at an acceptable exposure level
Human and Experimental Toxicology, January 1, 2006; 25(1): 23 - 27.
[Abstract] [PDF]

Home page
 Hum Exp ToxicolHome page
J. A Pickrell and F. W Oehme
Examining the risks and benefits of replacing traditional dose-response with hormesis
Human and Experimental Toxicology, May 1, 2005; 24(5): 259 - 264.
[Abstract] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.